Otsuka Pharmaceutical Co., Ltd.

Japan · Reporting entity ID 100000000112

Total reported 2019–2025

$59.0M

#149 of 2,960 reporting companies — 0.1% of all reported industry payments

$2.62M in general payments across 862 records, plus $56.4M in research funding across 4,951 records.

How it breaks down

General payments $2,620,706

Research funding $56,351,002

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.